GlassScriptPhysician profile
Michael Sean Mccormack
NPI 1710304670
$35,319.86
in general payments reported to CMS, 2019-2025
26 companies · $4,686 in 2025
The $4,686 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25K · 2021: $112 · 2022: $2,787 · 2023: $911 · 2024: $1,813 · 2025: $4,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,388 · Travel and Lodging: $1,344 · Consulting Fee: $1,000 · Education: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,387.81 |
| Travel and Lodging | $1,343.68 |
| Consulting Fee | $1,000.00 |
| Education | $678.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $26,234.45 | 2020-2025 | Spyglass Discover, General - Therapies, Axios |
| Ets Wound Care LLC | $2,516.16 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Medtronic, INC. | $1,552.94 | 2022-2025 | Signia, Bravo, Transorb |
| Medical Device Business Services, INC. | $1,189.89 | 2022 | |
| Stryker Corporation | $1,035.36 | 2024-2025 | 1788 |
| Apollo Endosurgery US INC | $539.19 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Kerecis Limited | $433.30 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| W. L. Gore & Associates, INC. | $242.62 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Mimedx Group, INC. | $224.12 | 2025 | |
| Ethicon US, LLC | $170.09 | 2024 | Echelon Circular, Echelon Endopath, Harmonic |
| Inari Medical, INC. | $167.30 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Creo Medical INC. | $151.30 | 2023 | Speedboat |
| Intuitive Surgical, INC. | $150.01 | 2023-2024 | Da Vinci Surgical System |
| Chiesi USA, INC. | $147.42 | 2024 | Cleviprex |
| Vertex Pharmaceuticals Incorporated | $143.32 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $79.07 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Baxter Healthcare | $61.32 | 2024 | Perclot |
| Davol INC. | $46.05 | 2025 | Phasix Mesh |
| Reapplix INC. | $45.77 | 2024-2025 | 3c Patch Kit - Box |
| Madrigal Pharmaceuticals | $45.25 | 2025 | Rezdiffra |
| Pacira Pharmaceuticals Incorporated | $39.61 | 2025 | Exparel |
| Tela Bio, INC. | $35.74 | 2024 | Ovitex 2s |
| Merck Sharp & Dohme LLC | $23.75 | 2024 | Bridion |
| Cashflow Solutions, LLC | $18.21 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Takeda Pharmaceuticals U.S.A., INC. | $16.38 | 2023 | Entyvio |
| Allergan, INC. | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mccormack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.